Journal Information
Vol. 10. Issue 5.
Pages 350-357 (January 1999)
Share
Share
Download PDF
More article options
Vol. 10. Issue 5.
Pages 350-357 (January 1999)
Tratamiento con radiocirugía estereotáxica del glioma cerebral primario de alto grado
Stereotactic radiosurgery in primary high grade malignat glioma
Visits
2790
D. Ortiz de Urbina, M. Santos, J. Samblás, J.M. Delgado, J.C. Bustos, J.A. Gutiérrez-Díaz, I. García-Berrocal, S. Rodríguez, M.C. Rubio, G. Donckaster, F. Sansivirini, F.A. Calvo
Sanatorio San Francisco de Asís. Madrid
This item has received
Article information
Resumen
Objetivo

Analizar en un estudio fase II el control local, tiempo a progresión y supervivencia (SPV) de pacientes con glioma cerebral primario de alto grado tratados con radiocirugía estereotáxica (RC), como tratamiento de intensificación local.

Material y métodos

Dieciocho pacientes, 8 astrocitomas anaplásicos y 10 glioblastomas multiformes de diámetro máximo menor o igual a 5cm, han sido tratados con RC, administrándose una dosis margen que incluye el volumen tumoral de 10–20 Gy (mediana: 15 Gy), alcanzando una dosis máxima intratumoral de 12.5–40 Gy (mediana 17 Gy). Catorce pacientes (78%) recibieron radioterapia externa fraccionada (mediana de dosis: 60 Gy).

Resultados

La mediana de SPV ha sido 11.5 meses y la SPV actuarial a 1 y 2 años de 42.5% y 10.6% respectivamente. Diez de 18 pacientes (55%) presentaron progresión tumoral con una mediana de tiempo a progresión de 10 meses (límites: 1–14 meses). Sólo 1 paciente (5.5%) desarrolló toxicidad severa.

Conclusiones

La RC es una atractiva modalidad de tratamiento de intensificación local en glioma maligno cerebral de tamaño menor o igual a 5cm, tolerable y factible.

Palabras clave:
Radiocirugía estereotáxica
Glioma cerebral de alto grado
Summary
Objective

To analyze in a phase II clinical trial the local control, time to progression and survival of patients with primary malignant glioma treated with stereotactic radiosurgery (SRS) as a treatment boost.

Methods and material A total of 18 patients, with anaplastic astrocytomas (8 cases) and glioblastoma multiformes (10 cases) (maximum diameter=5cm) have been treated with SRS, receiving a single marginal tumor dose of 10–20 Gy (median: 15 Gy), at 90% isodose line, and achieving a maximun tumor dose of 12.5–40 Gy (median: 17 Gy). Fourteen patients (78%) were treated with external beam radiotherapy (median dose: 60 Gy).

Results

The median survival time was 11.5 months, and the 1 -and 2-year actuarial survival were 42.5% and 10.6% respectively. Ten out of 18 patients (55%) had tumor progression and the median time to tumor progression was 10 months (range: 1–14 months). One patient (5.5%) developed severe toxicity.

Conclusion

SRS is an attractive, feasible and tolerable treatment modality for local intensification in malignant glioma, lesser o equal than 5cm in size.

Key words:
Stereotactic Radiosurgety
High grade glioma

Article

These are the options to access the full texts of the publication Neurocirugía (English edition)
Member
Member of the Sociedad Española de Neurocirugía

If it is the first time you have accessed you can obtain your credentials by contacting Elsevier Spain in suscripciones@elsevier.com or by calling our Customer Service at902 88 87 40 if you are calling from Spain or at +34 932 418 800 (from 9 to 18h., GMT + 1) if you are calling outside of Spain.

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option ¿I have forgotten my password¿.

Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Neurocirugía (English edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Idiomas
Neurocirugía (English edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?